A simple fitness tracker might hold the key to revolutionizing maternal health care. Scientists at Scripps Research have ...

No decline in lung function observed at 6-week interim analysis builds upon positive safety and biomarker data. Phase 2a study fully enrolled; Topline data on track for Q3 2025. C ...

GRI Bio (GRI) reported interim 6-week lung function results from its ongoing Phase 2a study evaluating GRI-0621 for the treatment of Idiopathic ...

Objectives Hamstring strain injury (HSI) is the most common time-loss injury in football and is prone to recurrence. This ...

BXCL501 demonstrated a significant mean reduction in mCGI-S score from baseline compared to placebo at 2 hours across 2,433 treated episodes ...

Late-breaking data from exploratory analyses at WCLC show Libtayo plus chemotherapy demonstrates a more than double five-year overall survival ...

Perioperative nivolumab in eligible patients with resectable non-small cell lung cancer offers improved survival outcomes and ...

Industry watchers who cheered on Summit Therapeutics’ claim that the first global phase 3 trial of its Akeso-partnered ...

The new agent upgrades the Databricks Assistant, enabling it to help data practitioners complete repetitive tasks and ...

MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider. MtoZ Biolabs offers High-throughput ...

Traditional tissue biopsy is invasive, time-consuming, and often impractical in advanced or metastatic disease. Liquid biopsy—non-invasive sampling of circulating tumor DNA (ctDNA), circulating tumor ...

Master Planning Advisory Committee (MPAC) met for the first time on Monday, Aug. 25, after a four-month break. All members of ...